A drug-coated balloon treatment for urethral stricture disease: Two-year results from the ROBUST I study.

CONCLUSIONS: Two-year data indicates the Optilume™ paclitaxel-coated balloon is safe for the treatment of recurrent bulbar urethral strictures. Early efficacy results are encouraging and support further followup of these men through five years, as well as further investigation with a randomized trial.
PMID: 32744999 [PubMed - as supplied by publisher]

Source: Canadian Urological Association Journal - July 26, 2020 Category: Urology & Nephrology Authors: Mann RA, Virasoro R, DeLong JM, Estrella RE, Pichardo M, Lay RR, Espino G, Roth JD, Elliott SP Tags: Can Urol Assoc J Source Type: research